BNP PARIBAS ASSET MANAGEMENT Holding S.A. Cuts Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

BNP PARIBAS ASSET MANAGEMENT Holding S.A. lowered its position in The Cooper Companies, Inc. (NASDAQ:COO) by 14.2% during the third quarter, Holdings Channel.com reports. The fund owned 432,216 shares of the medical device company’s stock after selling 71,423 shares during the quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A.’s holdings in Cooper Companies were worth $47,691,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in COO. Janus Henderson Group PLC increased its position in shares of Cooper Companies by 279.8% in the first quarter. Janus Henderson Group PLC now owns 3,437,064 shares of the medical device company’s stock worth $348,723,000 after acquiring an additional 2,532,186 shares in the last quarter. Swedbank AB acquired a new stake in Cooper Companies in the 1st quarter valued at $139,246,000. Point72 Asset Management L.P. raised its position in Cooper Companies by 480.1% in the second quarter. Point72 Asset Management L.P. now owns 937,806 shares of the medical device company’s stock valued at $81,870,000 after purchasing an additional 776,140 shares during the period. Victory Capital Management Inc. lifted its stake in shares of Cooper Companies by 23.0% during the third quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock worth $435,856,000 after purchasing an additional 737,726 shares in the last quarter. Finally, Magnetar Financial LLC acquired a new position in shares of Cooper Companies during the second quarter worth about $63,822,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Analysts Set New Price Targets

COO has been the topic of several analyst reports. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a report on Thursday, August 29th. Wells Fargo & Company lifted their price objective on shares of Cooper Companies from $110.00 to $115.00 and gave the company an “overweight” rating in a research note on Thursday, August 29th. Piper Sandler upped their target price on shares of Cooper Companies from $115.00 to $120.00 and gave the company an “overweight” rating in a research note on Thursday, August 29th. Robert W. Baird lifted their price target on shares of Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a research note on Thursday, August 29th. Finally, StockNews.com cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday. Four analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Cooper Companies presently has a consensus rating of “Moderate Buy” and an average target price of $117.00.

Cooper Companies Stock Performance

Shares of COO stock opened at $99.96 on Friday. The stock has a market capitalization of $19.91 billion, a price-to-earnings ratio of 55.69, a PEG ratio of 2.14 and a beta of 0.99. The Cooper Companies, Inc. has a one year low of $82.21 and a one year high of $112.38. The company’s 50-day simple moving average is $106.11 and its 200-day simple moving average is $98.20. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.18 and a current ratio of 1.99.

Cooper Companies (NASDAQ:COO) last released its earnings results on Wednesday, August 28th. The medical device company reported $0.96 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.05. The company had revenue of $1 billion for the quarter, compared to the consensus estimate of $997.30 million. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. Cooper Companies’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same quarter last year, the business posted $0.84 EPS. Equities analysts anticipate that The Cooper Companies, Inc. will post 3.65 earnings per share for the current fiscal year.

Insider Buying and Selling at Cooper Companies

In related news, CAO Agostino Ricupati sold 1,601 shares of the business’s stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $108.03, for a total transaction of $172,956.03. Following the completion of the transaction, the chief accounting officer now owns 4,818 shares in the company, valued at $520,488.54. The trade was a 24.94 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Albert G. White III sold 114,992 shares of the company’s stock in a transaction on Thursday, September 19th. The stock was sold at an average price of $110.53, for a total value of $12,710,065.76. Following the transaction, the chief executive officer now owns 165,273 shares of the company’s stock, valued at approximately $18,267,624.69. The trade was a 41.03 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 256,373 shares of company stock worth $27,637,427 over the last 90 days. Insiders own 2.00% of the company’s stock.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.